Trinity Biotech, the Bray-based maker of medical diagnostic equipment, plans to “aggressively” buy back its stock in a bid to lift its share price, which collapsed this month after it failed to secure regulatory approval for a new test for heart attacks.
The company said last week that it had about $85 million of cash in the bank and while it had looked at a number of potential acquisitions to boost its growth,...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team